Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$209.01 - $232.56 $9.13 Million - $10.2 Million
43,664 Added 1053.41%
47,809 $10.4 Million
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $112,090 - $128,873
-567 Reduced 12.03%
4,145 $942,000
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $2.28 Million - $2.52 Million
-11,360 Reduced 70.68%
4,712 $947,000
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $10.1 Million - $11.5 Million
-47,647 Reduced 74.78%
16,072 $3.88 Million
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $8.03 Million - $9.71 Million
37,663 Added 144.55%
63,719 $14.6 Million
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $4.34 Million - $5.3 Million
-21,301 Reduced 44.98%
26,056 $6.13 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $5.92 Million - $7.58 Million
28,925 Added 156.93%
47,357 $9.7 Million
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $6.5 Million - $8.45 Million
-30,407 Reduced 62.26%
18,432 $4.32 Million
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $3.92 Million - $4.49 Million
15,071 Added 44.63%
48,839 $12.9 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $3.15 Million - $3.64 Million
-11,598 Reduced 25.57%
33,768 $10.6 Million
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $443,009 - $497,044
-1,612 Reduced 3.43%
45,366 $12.8 Million
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $12.6 Million - $13.9 Million
-50,102 Reduced 51.61%
46,978 $13 Million
Q1 2021

May 17, 2021

SELL
$204.88 - $255.03 $3.92 Million - $4.88 Million
-19,143 Reduced 16.47%
97,080 $24.8 Million
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $17.6 Million - $20.2 Million
94,000 Added 422.99%
116,223 $23.7 Million
Q3 2020

Nov 16, 2020

BUY
$167.03 - $201.3 $3.71 Million - $4.47 Million
22,223 New
22,223 $4.18 Million
Q2 2020

Aug 14, 2020

SELL
$113.31 - $182.44 $3.44 Million - $5.54 Million
-30,352 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$104.32 - $195.28 $10.5 Million - $19.7 Million
-100,916 Reduced 76.88%
30,352 $3.84 Million
Q4 2019

Feb 18, 2020

BUY
$163.48 - $173.61 $15.1 Million - $16 Million
92,066 Added 234.85%
131,268 $22.2 Million
Q3 2019

Nov 14, 2019

SELL
$159.77 - $178.1 $8.73 Million - $9.73 Million
-54,635 Reduced 58.22%
39,202 $6.59 Million
Q2 2019

Aug 14, 2019

BUY
$144.16 - $172.9 $1.25 Million - $1.5 Million
8,654 Added 10.16%
93,837 $16.2 Million
Q1 2019

May 15, 2019

SELL
$123.7 - $156.3 $2.92 Million - $3.69 Million
-23,589 Reduced 21.69%
85,183 $13 Million
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $7.3 Million - $10.5 Million
-60,444 Reduced 35.72%
108,772 $13.7 Million
Q3 2018

Nov 14, 2018

BUY
$167.67 - $188.27 $7.56 Million - $8.48 Million
45,063 Added 36.3%
169,216 $29.4 Million
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $2.95 Million - $3.49 Million
18,429 Added 17.43%
124,153 $22.3 Million
Q1 2018

May 15, 2018

BUY
$161.53 - $178.11 $17.1 Million - $18.8 Million
105,724 New
105,724 $17.1 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.